Cinda Securities(SH:601059) Ge Long Hui·2025-09-03 02:40Core Insights - Ark Health (6086.HK), known as the "first stock in AI chronic disease management," saw its stock price surge by 9% at the beginning of trading, currently priced at 4.22 HKD, with a total market capitalization of 5.66 billion HKD [1] - The company reported a revenue of 1.494 billion HKD for the first half of 2025, representing a year-on-year growth of 12.9%. Net profit turned positive at 12.5 million HKD, while adjusted net profit reached a new high of 17.6 million HKD, up 16.8% year-on-year [1] Financial Performance - For the first half of 2025, Ark Health achieved a net profit turnaround, with expectations for further performance improvement in the second half of 2025 alongside advancements in AI initiatives [1] - The company has over 11 million monthly active users with a repurchase rate of 85% [1] - As of June 30, 2025, the platform registered 52.8 million users, with an average of 11.9 million monthly active users over the past twelve months [1] Business Model and AI Integration - The company focuses on specialized fields such as weight loss, metabolic disorders, and infectious diseases [1] - Ark Health has deployed an "AI triage assistant" to help patients select doctors and appropriate departments, and launched an "AI doctor assistant" to support physicians in diagnosis and treatment [1] - The company upgraded its "AI customer service assistant" to enhance medication management throughout the patient journey, creating an innovative business model that improves physician efficiency and manages patients' entire lifecycle [1]